Abbott Laboratories (ABT)

All Comments on ABT

  • commenter
    mangy cat
    Aug 15 08:21 PM
    Companies With Recent, Innovative Product Approvals vs. Healthcare ETFs [view article]
    but this is hindsight
    and investment is foresight     Reply
  • commenter
    User 199792
    Aug 15 01:02 PM
    Abbott Labs Beefs Up Its Drug Portfolio and Stent Business [view article]
    ABT has a lot in the pipeline Reply
  • commenter
    truthinvesti
    ng
    Aug 02 04:09 PM
    My Website
    PowerShares FTSE RAFI Healthcare: Big Bets on Dow Dogs [view article]
    nice article in my bargain bin thread those top 3 holdings are all my selections as well. Reply
  • commenter
    kkin365
    Aug 01 09:23 AM
    My Website
    PowerShares FTSE RAFI Healthcare: Big Bets on Dow Dogs [view article]
    Thanks for giving us the 10 top holdings. Reply
  • commenter
    GRR
    Jul 30 08:29 AM
    The State of Statins and Stents [view article]
    Redbaron - The cancer issues was assessed by an independent group, it was not done by "the company". They looked at the meta analysis of the data on patients taking Vytorin to date in several large studies. That's how they came up with the "anomaly" term for what happened in the SEAS trial. It was an anomaly, based on the other data available on thousands of patients who have taken this med. Also, they (or the FDA or anyone else) can not say that there is or is not increased longevity from Vytorin because that sudy is not completed yet. Reply
  • commenter
    iThinkBig
    Jul 29 09:14 PM
    My Website
    Abbott Laboratories: The Choice Within Big Pharma [view article]
    I agree with his basic analysis about big pharma. I won't comment much further, two of my clients are Astra Zeneca and Merck. He is correct about diagnostics (ie Clinical Trials) are going to boom in emerging markets. U.S. labor has become a lot cheaper these days. It is a shame our political system skews toward Chronie Capatalism. My big pharma contacts want to keep there money here but the political situation is causing them to do what any good capatalist does, invest where it is safest. Reply
  • commenter
    jrhc
    Jul 27 05:01 PM
    The State of Statins and Stents [view article]
    The higher number of cancer may be called 'anomaly' because ezitimibe doesn't show potential to damage DNA or other 'pro cancer' properties. The only way to close the issue is longer observational studies (like the Nurses' Health Study I and II studies) with more than 40,000 people. Reply
  • commenter
    CLH
    Jul 27 01:58 PM
    The State of Statins and Stents [view article]
    If the drug company believes the cancer cases are an anomaly, the FDA should ask for a larger study. In fact the drug company should do it on their own to protect themselves.

    No drug companies are not evil.     Reply
  • commenter
    redbaron
    Jul 27 11:54 AM
    The State of Statins and Stents [view article]
    'The companies say the higher number of cancer cases is likely an anomaly.'

    I don't see how they can have it both ways, i.e., how can the drug co.'s use the data to legitimately support the use of statins, and at the same time selectively ignore the rest of the data as an 'anomaly'? And, I might add, ignore the data that shows no benefit in terms of additional longevity from the use of statins.

    One could as easily use the same data to 'selectively' conclude, 1) there is no increased longevity from these drugs, and 2) there is a 50% additional risk from cancer deaths. Again, this is selectively using the data, but isn't that what the drug companies are doing?

    How can an individual private practice doc make rational decisions for their patients, when the drug companies are self promoting the drugs in this fashion? The standard of care dictates one thing, and one could selectively interpret the data in quite the oposite fashion.

    It would seem to me that we need good statistical independent interpretation of the data, with the key word being 'independent'. And additionally, it is quite apparent to me that the drug companies are not going to be the source of that interpretation. One would also have to wonder if our FDA is independent enough to perform this task.

    As for me, I will not take the drugs again.



    Reply
  • commenter
    User 232942
    Jul 26 12:36 PM
    My Website
    The Long Case for Abbott Laboratories [view article]
    Check out an interesting article on ABT here www.bullishbankers.com.../ Reply
  • commenter
    BullishBanke
    rs
    Jul 26 12:09 PM
    My Website
    The Long Case for Abbott Laboratories [view article]
    Check out www.bullishbankers.com.../ for more information on ABT, I thought it was great Reply
  • commenter
    etchdude
    Jul 24 10:11 AM
    The Long Case for Abbott Laboratories [view article]
    Remember a time when "analysts" didn't dictate what corporations should make?? Sorry to offend you, but the analysts are ruining it for the common people, creating a corporate greed structure that says "We didn't make ENOUGH money"... Thank you for screwing things up... Reply
  • commenter
    CrossProfit
    Jul 24 05:29 AM
    My Website
    The Long Case for Abbott Laboratories [view article]
    correction: 'when THERE should be"...where's the coffee! Reply
  • commenter
    CrossProfit
    Jul 24 04:57 AM
    My Website
    The Long Case for Abbott Laboratories [view article]
    Not sure how much more near term upside ABT has.
    See: www.crossprofit.com/vi...

    Would wait for annual reassessment in September/October when their should be more visibility for the upcoming twelve months.

    CrossProfit
    Disclosure: No conflicts.     Reply
  • commenter
    morgan77
    Jul 23 02:39 PM
    Just What the Doctor Ordered: Comparing the Pharma ETFs [view article]
    Pharmaceuticals are a great call right now. Anyone holding/thinking about holding PFE on it's own outside of the ETFs?
    PFE has a flawless 41-year history of dividend growth and stands to benefit big, along with the entire drug industry as Medicare Part D kicks in over the next few years.
    Here's an article by PFE supporter if you're interested in the dividend and management.

    www.greenfaucet.com/tr...

    Anyone else have any good information about PFE before I jump in?     Reply

Trading Center


Loading...
Symbols:
Authors:
Quick Links: